Results 41 to 50 of about 55,585 (143)

Update in the research of anti-N-methyl-D-aspartate receptor encephalitis

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2014
doi: 10.3969/j.issn.1672-6731.2014.08 ...
Jia-wei WANG
doaj  

Mercury-induced toxicity of rat cortical neurons is mediated through N-methyl-D-Aspartate receptors

open access: yesMolecular Brain, 2012
Background Mercury is a well-known neurotoxin implicated in a wide range of neurological or psychiatric disorders including autism spectrum disorders, Alzheimer’s disease, Parkinson’s disease, epilepsy, depression, mood disorders and tremor.
Xu Fenglian   +6 more
doaj   +1 more source

The GluN3 subunit regulates ion selectivity within native N-methyl-d-aspartate receptors

open access: yesIBRO Reports, 2020
Glutamatergic N-methyl-d-aspartate receptors (NMDARs) are heterotetrameric proteins whose subunits are derived from three gene families, GRIN1 (codes for GluN1), GRIN2 (GluN2) and GRIN3 (GluN3).
Stephen Beesley   +2 more
doaj  

Derivatives of methoxetamine and major methoxetamine metabolites potently block NMDA receptors

open access: yesJournal of Pharmacological Sciences, 2022
N-Methyl-D-aspartate receptors (NMDARs) in the brain are influenced by psychoactive drugs such as 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one (ketamine) and its analog 2-(ethylamino)-2-(3-methoxyphenyl)-cyclohexanone (methoxetamine).
Tomohiko Irie   +4 more
doaj  

Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors

open access: yesJournal of Neuroinflammation, 2004
Background Neuroinflammation plays a prominent role in the progression of Alzheimer's disease and may be responsible for degeneration in vulnerable regions such as the hippocampus.
Hauss-Wegrzyniak Beatrice   +3 more
doaj   +1 more source

Anti-N-methyl-D-aspartate receptor encephalitis: one case report

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2015
DOI: 10.3969/j.issn.1672-6731.2015.12 ...
Ying CHEN   +3 more
doaj  

Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke

open access: yesBrain, Behavior, & Immunity - Health, 2023
Background: Anti-NMDA-receptor GluN1 antibodies (NMDAR1-abs) are present in an autoimmune encephalitis with severe neuropsychiatric symptoms. We aimed to estimate the impact of serum NMDAR1-abs on depressive symptoms years after first-ever ischemic ...
Pia S. Sperber   +11 more
doaj  

A Comprehensive Review of the Ketamine Mechanism and Its Pleiotropic Effects [PDF]

open access: yesالمجلة العراقية للصيدلة
Objective: In the world of anesthetics, ketamine is unique. Over thirty years ago, the substance was first used in therapeutic practice to act as a "mono-anesthetic," causing analgesia, forgetfulness, loss of consciousness, and immobility.
Taqwa B. Thanoon, Zeina Althanoon
doaj   +1 more source

Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases

open access: yesInternational Journal of Molecular Sciences
N-methyl-d-aspartate receptors (NMDARs) are the main class of ionotropic receptors for the excitatory neurotransmitter glutamate. They play a crucial role in the permeability of Ca2+ ions and excitatory neurotransmission in the brain. Being heteromeric receptors, they are composed of several subunits, including two obligatory GluN1 subunits (eight ...
Carles, Allison   +4 more
openaire   +2 more sources

Dual Action of Memantine in Alzheimer Disease: A Hypothesis

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2009
Objective: In this study, we proposed a hypothesis to explain the mechanisms of memantine action in treating Alzheimer disease (AD). Memantine may reduce the expression of amyloid precursor protein and tau protein, as well as acting as an antagonist of N-
Tzong-Yuan Wu, Chih-Ping Chen
doaj   +1 more source

Home - About - Disclaimer - Privacy